In vivo xenograft experiments using Ishikawa cells supported the in vitro findings, confirming that LINC00958 promotes tumor growth by modulating the miR‐129‐2‐3p/NOTCH3 axis. This evidence concerns the gene NOTCH3 and neoplasm.